Alvotech announces closing of private debt financing

Alvotech (nasdaq: alvo), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the closing of its previously announced senior secured first lien term loan facility (the “facility”).  the closing has allowed alvotech to refinance outstanding debt obligations, reduce the cost of capital and improve its overall debt maturity profile.
ALVO Ratings Summary
ALVO Quant Ranking